ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 89 filers reported holding ANTARES PHARMA INC in Q1 2014. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $262,000 | +0.8% | 80,791 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $260,000 | +182.6% | 80,791 | -23.6% | 0.00% | – |
Q1 2016 | $92,000 | -24.0% | 105,808 | +5.6% | 0.00% | -100.0% |
Q4 2015 | $121,000 | -28.8% | 100,182 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $170,000 | -18.3% | 100,182 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $208,000 | -9.6% | 100,182 | +18.1% | 0.00% | 0.0% |
Q1 2015 | $230,000 | 0.0% | 84,802 | -5.2% | 0.00% | 0.0% |
Q4 2014 | $230,000 | +38.6% | 89,474 | -1.1% | 0.00% | 0.0% |
Q3 2014 | $166,000 | -30.3% | 90,481 | +1.4% | 0.00% | 0.0% |
Q2 2014 | $238,000 | -39.0% | 89,207 | +2.5% | 0.00% | -50.0% |
Q4 2013 | $390,000 | +7.1% | 87,026 | -3.0% | 0.00% | 0.0% |
Q3 2013 | $364,000 | +5.8% | 89,737 | +8.4% | 0.00% | 0.0% |
Q2 2013 | $344,000 | – | 82,789 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JW Asset Management, LLC | 1,671,956 | $5,384,000 | 3.43% |
ARMISTICE CAPITAL, LLC | 5,700,000 | $18,354,000 | 2.34% |
Rubric Capital Management LP | 3,188,600 | $10,267,000 | 2.12% |
Broadfin Capital, LLC | 4,803,528 | $15,467,000 | 1.88% |
THOMPSON DAVIS & CO., INC. | 192,734 | $621,000 | 1.00% |
Asymmetry Capital Management, L.P. | 199,655 | $643,000 | 0.76% |
Perceptive Advisors | 4,267,253 | $13,741,000 | 0.69% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 946,987 | $3,049,000 | 0.21% |
Brown Advisory Securities, LLC | 275,000 | $886,000 | 0.20% |
EAM Investors, LLC | 251,619 | $810,000 | 0.13% |